血管紧张素1-7在实验性感染性休克模型中的作用
该研究为随机、开放标签、对照实验,在14只麻醉机械通气的绵羊中,细菌性腹膜炎诱导脓毒症后立即静脉给予血管紧张素1-7(n=7)或安慰剂(n=7),4小时后启动液体复苏、抗菌治疗和腹腔灌洗,去甲肾上腺素滴定维持平均动脉压65-75 mmHg。结果显示血管紧张素1-7组7只中6只在24小时末未发生感染性休克,平均去甲肾上腺素剂量0.4 μg/kg/min vs 对照组4.3 μg/kg/min,实验末平均动脉血乳酸1.6 mmol/L vs 7.4 mmol/L,心率、心输出量指数、血浆白细胞介素-6和肌酐水平更低,血小板计数和PaO2/FiO2比值更高。作者结论认为早期输注血管紧张素1-7可预防感染性休克发生、减少去甲肾上腺素需求、限制白细胞介素-6升高并预防肾功能障碍。
要点
- 在细菌性腹膜炎诱导脓毒症的绵羊模型中,早期静脉输注血管紧张素1-7使7只中6只在24小时末未发生感染性休克。
- 血管紧张素1-7组平均去甲肾上腺素剂量为0.4 μg/kg/min,对照组为4.3 μg/kg/min,两组平均动脉压相似(目标65-75 mmHg)。
- 实验末平均动脉血乳酸:血管紧张素1-7组1.6 mmol/L vs 对照组7.4 mmol/L。
- 血管紧张素1-7组心率、心输出量指数、血浆白细胞介素-6和肌酐水平更低,血小板计数和PaO2/FiO2比值更高。
- 研究为动物实验,样本量小(14只绵羊),结论需在临床人群中进一步验证。
适用人群与场景
- 麻醉并机械通气的绵羊,经细菌性腹膜炎诱导脓毒症后立即开始干预。
处置流程与药物剂量
- 脓毒症诱导后立即静脉给予血管紧张素1-7(n=7)或安慰剂(n=7)。
- 脓毒症诱导4小时后启动液体复苏、抗菌治疗和腹腔灌洗。
- 去甲肾上腺素滴定维持平均动脉压(MAP)在65-75 mmHg。
研究设计与关键结果
- 研究类型:随机、开放标签、对照实验;样本量14只绵羊,血管紧张素1-7组n=7,对照组n=7。
- 两组基线特征无差异。
- 24小时末血管紧张素1-7组7只中6只未发生感染性休克。
- 两组液体平衡和MAP相似;血管紧张素1-7组平均去甲肾上腺素剂量0.4 μg/kg/min vs 对照组4.3 μg/kg/min。
- 血管紧张素1-7组心率、心输出量指数、血浆白细胞介素-6和肌酐水平低于对照组。
- 血管紧张素1-7组血小板计数和PaO2/FiO2比值高于对照组。
- 实验末平均动脉血乳酸:血管紧张素1-7组1.6 mmol/L vs 对照组7.4 mmol/L。
证据类型、等级与局限
- 证据类型:动物实验(随机、开放标签、对照研究)。
- 局限:样本量小(14只绵羊),需在临床人群中进一步验证。
对床旁实践的改变
- 作者认为,在此实验性感染性休克模型中,早期输注血管紧张素1-7可预防感染性休克发生、减少去甲肾上腺素需求、限制白细胞介素-6升高并预防肾功能障碍。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Alterations in the renin-angiotensin system have been implicated in the pathophysiology of septic shock. In particular, angiotensin 1-7 (Ang-(1-7)), an anti-inflammatory heptapeptide, has been hypothesized to have beneficial effects. The aim of the present study was to test the effects of Ang-(1-7) infusion on the development and severity of septic shock.
METHODS: This randomized, open-label, controlled study was performed in 14 anesthetized and mechanically ventilated sheep. Immediately after sepsis induction by bacterial peritonitis, animals received either Ang-(1-7) (n = 7) or placebo (n = 7) intravenously. Fluid resuscitation, antimicrobial therapy, and peritoneal lavage were initiated 4 h after sepsis induction. Norepinephrine administration was titrated to maintain mean arterial pressure (MAP) between 65 and 75 mmHg.
RESULTS: There were no differences in baseline characteristics between groups. Septic shock was prevented in 6 of the 7 animals in the Ang-(1-7) group at the end of the 24-h period. Fluid balance and MAP were similar in the two groups; however, MAP was achieved with a mean norepinephrine dose of 0.4 μg/kg/min in the Ang-(1-7) group compared to 4.3 μg/kg/min in the control group. Heart rate and cardiac output index were lower in the Ang (1-7) than in the control group, as were plasma interleukin-6 levels, and creatinine levels. Platelet count and PaO2/FiO2 ratio were higher in the Ang-(1-7) group. Mean arterial lactate at the end of the experiment was 1.6 mmol/L in the Ang-(1-7) group compared to 7.4 mmol/L in the control group.
CONCLUSIONS: In this experimental septic shock model, early Ang-(1-7) infusion prevented the development of septic shock, reduced norepinephrine requirements, limited interleukine-6 increase and prevented renal dysfunction.
参考来源
- Garcia B, Su F, Manicone F, et al. Angiotensin 1-7 in an experimental septic shock model. Crit Care. 2023. PMID: 36915144. doi:10.1186/s13054-023-04396-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。